Early trials probe COX-2 inhibitors' cancer-fighting potential.

Journal of the National Cancer Institute

Volumn 91, Issue 14, 1999, Pages 1186-1187

  Ziegler, J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; LACTONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; PYRAZOLE DERIVATIVE; ROFECOXIB; SULFONAMIDE; SULFONE;

ARTICLE; BLADDER TUMOR; CLINICAL TRIAL; COLON TUMOR; HUMAN; NEOPLASM; SKIN TUMOR;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; HUMANS; LACTONES; NEOPLASMS; PYRAZOLES; SKIN NEOPLASMS; SULFONAMIDES; SULFONES; URINARY BLADDER NEOPLASMS;

EID: 0033591794     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.14.1186     Document Type: Article

References (0)